ImmunoPrecise AntibodiesIPA 
$0.6613.99%24h
13.99%24h
Global rank30690
Market cap$16.43M
Change 7d13.79%
YTD Performance-59.51%
SP500 benchmarkUnderperform
P/E-0.62
P/S1.08
Revenue$15.18M
Earnings-$19.51M
Dividend yield-
EPS for ImmunoPrecise Antibodies (IPA)
ImmunoPrecise Antibodies has an EPS of $-1.07. In 2022, the company made an earnings per share (EPS) of $-0.85. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for IPA
-
Value:-
EPS history for ImmunoPrecise Antibodies from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$1.07 | 25.88% |
| 2022 | -$0.85 | 88.89% |
| 2021 | -$0.45 | 25.00% |
| 2020 | -$0.36 | - |
View the highest EPS stocks
